SCHEMBL5338217

SCHEMBL5338217

CN(C)Cc1ccccc1N1CCCN(C(=O)OC(C)(C)C)CC1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CKS1B P61024 2/20 0.50
SKP1 P63208 2/20 0.50
SKP2 Q13309 2/20 0.50
GPR119 Q8TDV5 3/20 0.46
MEN1 O00255 1/20 0.46
KMT2A Q03164 1/20 0.46
GAA P10253 1/20 0.46
SMN1; SMN2 Q16637 1/20 0.46
PLA2G7 Q13093 1/20 0.45
MGLL Q99685 1/20 0.45
ABHD6 Q9BV23 1/20 0.45
MC4R P32245 1/20 0.45
SMARCA2 P51531 1/20 0.43
SMARCA4 P51532 1/20 0.43
PBRM1 Q86U86 1/20 0.43
ACHE P22303 1/20 0.43
CHRM2 P08172 1/20 0.43
CHRM4 P08173 1/20 0.43
CHRM1 P11229 1/20 0.43
CHRM3 P20309 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4511470 0.95 GPR119 (0.50) CKS1BSKP1SKP2GPR119MEN1
SCHEMBL7986047 0.89 CKS1B (0.57) CKS1BSKP1SKP2GPR119MEN1
SCHEMBL2465277 0.86 NCF1 (0.56) CKS1BSKP1SKP2GPR119MEN1
SCHEMBL14387740 0.85 GPR119 (0.44) CKS1BSKP1SKP2GPR119GAA
SCHEMBL5336420 0.85 MC4R (0.45) CKS1BSKP1SKP2GPR119GAA
SCHEMBL7981893 0.84 GAA (0.56) CKS1BSKP1SKP2GPR119GAA
SCHEMBL5334482 0.83 MC4R (0.49) CKS1BSKP1SKP2GPR119GAA
SCHEMBL5343864 0.83 GPR119 (0.43) CKS1BSKP1SKP2GPR119GAA
SCHEMBL5336449 0.82 MC4R (0.49) CKS1BSKP1SKP2GPR119GAA
SCHEMBL615074 0.81 CHRM2 (0.52) CKS1BSKP1SKP2GPR119MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7291619-B2 Melanocortin receptor agonists ELI LILLY AND COMPANY (US) 2007-11-06 US disclosed
US-7291619-B2 Melanocortin receptor agonists ELI LILLY AND COMPANY (US) 2007-11-06 US disclosed
EP-1368340-B1 PIPERAZINE DERIVATIVES AS MELANOCORTIN RECEPTOR AGONISTS LILLY CO ELI (US) 2005-08-10 EP disclosed
US-20040092507-A1 Melanocortin receptor agonists ELI LILLY AND COMPANY 2004-05-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040092507-A1 Melanocortin receptor agonists MC1R, MC4R, MC5R CKS1B 4539/4885SKP1 2910/4885SKP2 4661/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.